Hitoshi Kuwata

Osaka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Evaluation of inadvertent stigmatization of individuals with diabetes by healthcare professionals.

Evaluation of inadvertent stigmatization of individuals with diabetes by healthcare professionals.

Journal: Journal of diabetes investigation

Published: April 14, 2026

The Efficacy of Imeglimin and Metformin on Insulin Sensitivity and Secretion Using Oral Minimal Model: Sub-Analysis of an Exploratory Randomised Controlled Trial.

The Efficacy of Imeglimin and Metformin on Insulin Sensitivity and Secretion Using Oral Minimal Model: Sub-Analysis of an Exploratory Randomised Controlled Trial.

Journal: Diabetes, obesity & metabolism

Published: January 10, 2026

ChREBP drives β-cell proliferation under metabolic stress but not in pregnancy-induced β-cell expansion.

ChREBP drives β-cell proliferation under metabolic stress but not in pregnancy-induced β-cell expansion.

Journal: Journal of diabetes investigation

Published: December 19, 2025

Circadian feeding promotion by Ninjin'yoeito counteracts frailty in aged mice.

Circadian feeding promotion by Ninjin'yoeito counteracts frailty in aged mice.

Journal: The journal of physiological sciences : JPS

Published: November 29, 2025

BALLAST study: A multicentre, open-label, randomized-controlled, 52-week clinical trial of the efficacy and safety of luseogliflozin in older Japanese adults with type 2 diabetes receiving leucine-enriched amino acid supplementation and physical exercise programme.

BALLAST study: A multicentre, open-label, randomized-controlled, 52-week clinical trial of the efficacy and safety of luseogliflozin in older Japanese adults with type 2 diabetes receiving leucine-enriched amino acid supplementation and physical exercise programme.

Journal: Diabetes, obesity & metabolism

Published: November 25, 2025

Endogenous GIP signaling is indispensable for DPP-4 inhibitor-mediated metabolic control in mice.

Endogenous GIP signaling is indispensable for DPP-4 inhibitor-mediated metabolic control in mice.

Journal: Journal of diabetes investigation

Published: November 12, 2025

Effects of High-Protein Nutritional Guidance on Sarcopenia-Related Parameters in Individuals Aged ≥ 75 Years with Type 2 Diabetes: An Exploratory Single-Arm Pre-Post Intervention Study.

Effects of High-Protein Nutritional Guidance on Sarcopenia-Related Parameters in Individuals Aged ≥ 75 Years with Type 2 Diabetes: An Exploratory Single-Arm Pre-Post Intervention Study.

Journal: Nutrients

Published: October 01, 2025

Retrospective comparison of the clinical effects of oral semaglutide and SGLT2 inhibitors treatment in patients with type 2 diabetes.

Retrospective comparison of the clinical effects of oral semaglutide and SGLT2 inhibitors treatment in patients with type 2 diabetes.

Journal: Journal of diabetes investigation

Published: September 12, 2025

Evaluate muscle mass when setting target body weight.

Evaluate muscle mass when setting target body weight.

Journal: Diabetes, obesity & metabolism

Published: August 29, 2025

Early induction of insulin sensitisation treated by tirzepatide: a prospective, single-arm, open-label study in Japanese individuals with obesity and type 2 diabetes.

Early induction of insulin sensitisation treated by tirzepatide: a prospective, single-arm, open-label study in Japanese individuals with obesity and type 2 diabetes.

Journal: Diabetologia

Published: February 11, 2025

Dietary Protein Intake Is a Determining Factor for Skeletal Muscle Mass in Japanese Older People with Type 2 Diabetes: A Cross-Sectional Study.

Dietary Protein Intake Is a Determining Factor for Skeletal Muscle Mass in Japanese Older People with Type 2 Diabetes: A Cross-Sectional Study.

Journal: Nutrients

Published: January 25, 2025

Short-term outcomes of switching from GLP-1 receptor agonists to tirzepatide in type 2 diabetes: A retrospective, observational study in clinical practice.

Short-term outcomes of switching from GLP-1 receptor agonists to tirzepatide in type 2 diabetes: A retrospective, observational study in clinical practice.

Journal: Diabetes, obesity & metabolism

Published: December 19, 2024

Showing 1-12 of 43

Last Updated: 09/26/2026